SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PTCT

Ptc Therapeutics, Inc. (PTCT)

NASDAQ: PTCT · Real-Time Price · USD
Healthcare · Biotechnology
60.52-0.07 (-0.11%)
 
Market cap
$5.05B
Insider Score
Analyst consensus
Website
Insider Score
/ 100
PTCT Insider Score

PTC THERAPEUTICS, INC. has a live Insider Score.

Scored on 0 qualifying trades from 0 insiders in the last 90 days.

Unlock the score

PTCT Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue360.52 M272.55 M164.68 M211.01 M178.88 M1.18 B
Revenue Growth (YoY)101.55 %-76.83 %-22.75 %7.23 %-4.19 %459.73 %
Cost of Revenue19.92 M28.03 M16.30 M115.94 M11.42 M12.86 M
Gross Profit340.60 M244.52 M148.38 M95.07 M167.46 M1.16 B
SG&A Expense80.63 M86.18 M100.47 M84.05 M85.26 M80.96 M
R&D Expense99.15 M100.87 M133.13 M100.16 M112.99 M108.97 M
Operating Expenses191.62 M198.64 M230.00 M92.05 M202.41 M193.01 M
Operating Income148.98 M45.89 M-81.62 M3.02 M-34.96 M970.23 M
Pretax Income97.55 M-2.46 M-139.08 M-23.07 M-71.05 M929.83 M
Tax Provision14.05 M347.00 K-4.12 M-38.97 M-6.20 M63.27 M
Net Income83.50 M-2.81 M-134.97 M15.90 M-64.85 M866.56 M
EPS (Basic)1.01-0.03-1.670.20-0.8311.09
EPS (Diluted)0.92-0.03-1.670.20-0.8310.04
Shares Outstanding83.01 M82.52 M80.69 M81.50 M78.15 M78.12 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.